The Stool DNA Test Is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 3, 2012, Pages

  Ahlquist, David A ^a   Taylor, William R ^a   Mahoney, Douglas W ^a   Zou, Hongzhi ^b   Domanico, Michael ^b   Thibodeau, Stephen N ^a   Boardman, Lisa A ^a   Berger, Barry M ^b   Lidgard, Graham P ^b  

^a MAYO CLINIC   (United States)

^b Exact Sciences Corporation   (United States)

Author keywords

Adenoma Detection; Colorectal Cancer; Plasma Septin 9; Stool DNA

Indexed keywords

BETA ACTIN; DNA; HEMOGLOBIN; K RAS PROTEIN; NDRG4 PROTEIN; OSTEOGENIN; PROTEIN; SEPTIN; SEPTIN 9; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL TUMOR; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FALSE POSITIVE RESULT; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

EID: 84857194577     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.10.008     Document Type: Article

References (21)

1. Ahlquist D.A. Molecular detection of colorectal neoplasia. Gastroenterology 2010, 138:2127-2139.
2. Tao S., Hundt S., Haug U., et al. Sensitivity estimates of blood-based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease. Am J Gastroenterol 2011, 106:242-253.
3. Lofton-Day C., Model F., Devos T., et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008, 54:414-423.
4. Grützmann R., Molnar B., Pilarsky C., et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 2008, 3:e3759.
5. deVos T., Tetzner R., Model F., et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009, 55:1337-1346.
6. Tänzer M., Balluff B., Distler J., et al. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One 2010, 5:e9061.
7. Heichman Ka WJ, Vaughn CP, Furtado LV, et al. Use of Septin 9 methylated DNA biomarker to detect cancer in the blood of colorectal cancer patients. Presented at ASCO-NCI-EORTC Meeting in Philadelphia, 2010.
8. Church T.R.W.M., Lofton-Day C., et al. Prospective clinical validation of an assay for methylated SEPT9 DNA in human plasma as a colorectal cancer Screening tool in average risk men and women ≥50 years. Gastroenterology 2010, 130:e18.
9. Olson J., Whitney D.H., Durkee K., et al. DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests. Diagn Mol Pathol 2005, 14:183-191.
10. Zou H., Harrington J.J., Klatt K.K., et al. A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2006, 15:1115-1119.
11. Zou H.A.H., Cao X., et al. Sensitive quantification of methylated markers with a novel methylation specific technology. Clin Chem 2010, 56:A199.
12. Zou H., Taylor W.R., Harrington J.J., et al. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology 2009, 136:459-470.
13. Diehl F., Schmidt K., Durkee K.H., et al. Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology 2008, 135:489-498.
14. Loktionov A., O'Neill I.K., Silvester K.R., et al. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin Cancer Res 1998, 4:337-342.
15. Ahlquist D.A., Harrington J.J., Burgart L.J., et al. Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum Pathol 2000, 31:51-57.
16. Itzkowitz S.H., Jandorf L., Brand R., et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007, 5:111-117.
17. Zou H., Jian X., Harrington J.J., et al. Quantitative stool DNA testing for detection of both colorectal cancer and advanced adenoma. Gastroenterology 2009, 136(5 Suppl 1). A625.
18. Ahlquist D.A., Zou H., Domanico M., et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012, 142:248-256.
19. Ahlquist D.A., Skoletsky J.E., Boynton K.A., et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000, 119:1219-1227.
20. Ahlquist D.A., Sargent D.J., Loprinzi C.L., et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008, 149:441-450.
21. Diehl F., Li M., Dressman D., et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A 2005, 102:16368-16373.